Globus Medical Income Statement (2011-2026) | GMED

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	251.02M	229.72M	250.02M	230.55M	263.65M	254.15M	274.50M	276.69M	291.62M	383.64M	616.53M	606.67M	629.69M	625.71M	657.29M	598.12M	745.34M	769.05M	826.42M	759.85M
Cost of Revenue (Quarter)	63.85M	58.55M	61.80M	59.17M	68.47M	65.50M	70.59M	70.83M	76.47M	135.39M	265.49M	241.49M	260.04M	270.51M	263.44M	195.40M	248.76M	252.53M	261.11M	234.07M
Gross Profit (Quarter)	187.17M	171.17M	188.22M	171.38M	195.18M	188.65M	203.91M	205.86M	215.14M	248.25M	351.05M	365.18M	369.65M	355.19M	393.86M	402.72M	496.58M	516.51M	565.31M	525.79M
Operating items
Amortization - Intangibles (Quarter)	4.62M	4.57M	4.56M	4.51M	4.39M	4.32M	4.51M	4.60M	4.55M	13.76M	28.12M	29.68M	29.71M	30.08M	29.91M	28.80M	30.19M	29.84M	105.22M	29.53M
Depreciation & Amortization - Total (Quarter)												17.34M	26.20M	28.09M	29.27M	28.97M	29.64M	30.08M
Research & Development (Quarter)	15.55M	15.85M	51.02M	17.41M	17.39M	18.70M	19.51M	21.08M	21.35M	29.33M	52.25M	12.60M	37.70M	35.38M	33.41M	33.06M	39.95M	38.07M	36.16M	36.51M
Selling, General & Administrative (Quarter)	107.25M	96.44M	106.56M	100.75M	106.72M	106.58M	118.08M	122.42M	120.07M	156.21M	245.15M	248.68M	239.45M	240.06M	253.17M	242.80M	303.62M	313.60M	318.48M	297.77M
Restructuring Costs (Quarter)	13.87M	0.36M	2.48M	2.34M	-1.10M	-0.65M	4.17M	1.36M	5.71M	45.62M	68.09M	2.42M	13.73M	-3.62M	17.09M	1.06M	33.16M	-2.71M	10.83M	6.38M
Other Operating Expenses (Quarter)	4.62M	5.18M	9.97M	4.44M	4.39M	-14.06M	-512.54M	4.60M	1.81M	49.42M	88.82M	-253.49M	-302.88M	-282.50M	-325.77M	-297.12M	-383.98M	-372.74M
Operating Expenses (Quarter)	141.29M	117.84M	170.03M	124.94M	127.40M	128.95M	-370.78M	149.46M	148.93M	247.84M	-519.36M	27.55M	14.20M	17.41M	7.17M	8.77M	22.39M	6.29M	365.47M	340.66M
Operating Income (Quarter)	45.88M	53.33M	18.20M	46.45M	67.78M	59.70M	54.03M	56.40M	66.21M	0.40M	10.12M	8.00M	49.62M	48.10M	60.27M	97.00M	76.11M	137.36M	169.34M	150.39M
EBIT (Quarter)	45.88M	53.33M	18.20M	46.45M	67.78M	59.70M	54.03M	56.40M	66.21M	0.40M	10.12M	8.00M	49.62M	48.10M	60.27M	97.00M	76.11M	137.36M	169.34M	150.39M
Non-operating items
Interest & Investment Income (Quarter)																1.68M				5.43M
Other Non Operating Income (Quarter)	0.21M	-0.90M	9.42M	2.45M	2.76M	-2.21M	-8.00M	6.79M	-0.55M	-5.31M	-2.46M	-15.37M	-0.70M	-0.57M	5.79M		0.77M	-0.16M	117.70M	-2.11M
Non Operating Income (Quarter)	3.06M	1.12M	1.63M	2.45M	2.76M	1.76M	8.09M	6.79M	8.46M	-0.47M	-2.46M	0.71M	1.00M	8.93M	-46.41M	6.66M	0.77M	6.63M	-121.95M	2.25M
Net income details
EBT (Quarter)	48.93M	54.45M	19.83M	48.90M	70.54M	61.47M	62.12M	63.19M	74.67M	2.54M	24.99M	-8.56M	47.58M	57.03M	24.67M	103.67M	188.17M	143.99M	169.23M	157.07M
Tax Provisions (Quarter)	7.39M	7.24M	22.37M	10.81M	15.95M	14.03M	34.38M	14.06M	16.96M	1.54M	9.96M	-1.44M	15.82M	5.20M	-1.84M	28.21M	-14.67M	25.03M	28.64M	32.77M
Profit After Tax (Quarter)	41.55M	47.21M	15.11M	38.08M	54.59M	47.43M	50.06M	49.13M	57.71M	1.00M	15.03M	-7.12M	31.76M	51.84M	26.50M	75.46M	202.85M	118.97M	140.59M	124.30M
Income from Continuing Operations (Quarter)	41.55M	47.21M	-2.54M	38.08M	54.59M	47.43M	27.73M	49.13M	57.71M	1.00M	15.03M	-7.12M	31.76M	51.84M	26.50M	75.46M	202.85M	118.97M	140.59M	124.30M
Consolidated Net Income (Quarter)	41.55M	47.21M	-2.54M	38.08M	54.59M	47.43M	27.73M	49.13M	57.71M	1.00M	15.03M	-7.12M	31.76M	51.84M	26.50M	75.46M	202.85M	118.97M	140.59M	124.30M
Income towards Parent Company (Quarter)	41.55M	47.21M	-2.54M	38.08M	54.59M	47.43M	27.73M	49.13M	57.71M	1.00M	15.03M	-7.12M	31.76M	51.84M	26.50M	75.46M	202.85M	118.97M	140.59M	124.30M
Net Income towards Common Stockholders (Quarter)	41.55M	47.21M	-2.54M	38.08M	54.59M	47.43M	27.73M	49.13M	57.71M	1.00M	15.03M	-7.12M	31.76M	51.84M	26.50M	75.46M	202.85M	118.97M	140.59M	124.30M
Additional items
EPS (Basic) (Quarter)	0.41	0.47	0.15	0.37	0.54	0.48	0.50	0.49	0.57	0.01	0.06	-0.05	0.23	0.38	0.20	0.55	1.50	0.88	1.05	0.92
EPS (Weighted Average and Diluted) (Quarter)	0.40	0.45	0.14	0.37	0.53	0.47	0.49	0.48	0.57	0.01	0.09	-0.05	0.23	0.38	0.19	0.54	1.49	0.88	1.02	0.90
Shares Outstanding (Weighted Average) (Quarter)	100.16M	100.48M	100.73M	101.60M	101.14M	100.64M	100.47M	100.28M	100.33M	113.54M	113.09M	135.36M	135.28M	135.62M	135.73M	136.76M	135.98M	134.50M	135.22M	135.36M
Shares Outstanding (Diluted Average) (Quarter)											114.63M				137.86M	139.77M			137.06M	138.19M
EBITDA (Quarter)	41.80M	45.73M	11.39M	27.69M	46.39M	40.57M	57.66M	54.34M	58.07M	1.33M	23.58M	-7.97M	30.95M	56.72M	26.61M	80.16M	215.25M	119.65M	145.01M	123.36M
Tax Rate (Quarter)	15.10%	13.30%	112.83%	22.12%	22.61%	22.83%	55.35%	22.25%	22.71%	60.63%	39.85%	16.84%	33.25%	9.11%	-7.45%	27.21%	-7.80%	17.38%	16.92%	20.86%

Research Tools

Globus Medical Income Statement (2011-2026) | GMED

Create an account

Sign In

Reset Password